Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc., 56474 [2019-23012]
Download as PDF
<![CDATA[
56474
Federal Register / Vol. 84, No. 204 / Tuesday, October 22, 2019 / Notices
preliminarily determined meets the
requirements of the Criteria. The
following Plans are available for review:
• City of Tracy.
• Clear Creek Community Services
District.
• Sacramento County Water Agency.
• Westlands Water District.
We invite the public to comment on
our preliminary (i.e., draft)
determination of Plan adequacy.
A copy of these Plans will be
available for review at Reclamation’s
Mid-Pacific Regional Office, 2800
Cottage Way, CGB–410, Sacramento, CA
95825. If you wish to review a copy of
these Plans or to receive an electronic
copy via email, please contact Ms.
Stemen or visit https://www.usbr.gov/
mp/watershare/wcp.html.
Dated: October 16, 2019.
Richard Woodley,
Regional Resources Manager, Mid-Pacific
Region, Bureau of Reclamation.
[FR Doc. 2019–22958 Filed 10–21–19; 8:45 am]
BILLING CODE 4332–90–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 10, 2019,
Johnson Matthey, Inc., 2003 Nolte Drive,
West Deptford, New Jersey 08066–1743
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–524]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey, Inc.
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 23, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
Notice of application.
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Dihydromorphine .....................................................................................................................................................
Difenoxin ..................................................................................................................................................................
Amphetamine ..........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ...................................................................................................................................................
Methylphenidate ......................................................................................................................................................
Nabilone ..................................................................................................................................................................
Cocaine ...................................................................................................................................................................
Codeine ...................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ..............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................
Levorphanol .............................................................................................................................................................
Meperidine ...............................................................................................................................................................
Methadone ...............................................................................................................................................................
Methadone intermediate ..........................................................................................................................................
Morphine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Opium tincture .........................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for internal use as
intermediates or for sale to its
customers. In reference to drug codes
7360 (marihuana), and 7370
(tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Dated: October 9, 2019.
William T. McDermott,
Acting Assistant Administrator.
2010
7360
7370
9145
9168
1100
1105
1205
1724
7379
9041
9050
9120
9143
9150
9170
9180
9193
9220
9230
9250
9254
9300
9333
9630
9652
9668
9737
9739
9740
9780
9801
Schedule
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: (19–070)]
[FR Doc. 2019–23012 Filed 10–21–19; 8:45 am]
Name of Information Collection: NASA
Software Release Request System
BILLING CODE 4410–09–P
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of information
collection—new information collection.
AGENCY:
The National Aeronautics and
Space Administration, as part of its
SUMMARY:
VerDate Sep<11>2014
17:02 Oct 21, 2019
Jkt 250001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 84, Number 204 (Tuesday, October 22, 2019)]
[Notices]
[Page 56474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23012]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-524]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before December 23, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 10, 2019, Johnson Matthey, Inc., 2003 Nolte
Drive, West Deptford, New Jersey 08066-1743 applied to be registered as
a bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid....... 2010 I
Marihuana....................... 7360 I
Tetrahydrocannabinols........... 7370 I
Dihydromorphine................. 9145 I
Difenoxin....................... 9168 I
Amphetamine..................... 1100 II
Methamphetamine................. 1105 II
Lisdexamfetamine................ 1205 II
Methylphenidate................. 1724 II
Nabilone........................ 7379 II
Cocaine......................... 9041 II
Codeine......................... 9050 II
Dihydrocodeine.................. 9120 II
Oxycodone....................... 9143 II
Hydromorphone................... 9150 II
Diphenoxylate................... 9170 II
Ecgonine........................ 9180 II
Hydrocodone..................... 9193 II
Levorphanol..................... 9220 II
Meperidine...................... 9230 II
Methadone....................... 9250 II
Methadone intermediate.......... 9254 II
Morphine........................ 9300 II
Thebaine........................ 9333 II
Opium tincture.................. 9630 II
Oxymorphone..................... 9652 II
Noroxymorphone.................. 9668 II
Alfentanil...................... 9737 II
Remifentanil.................... 9739 II
Sufentanil...................... 9740 II
Tapentadol...................... 9780 II
Fentanyl........................ 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for internal use as intermediates or for sale to its
customers. In reference to drug codes 7360 (marihuana), and 7370
(tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetic. No other activities for these drug codes are
authorized for this registration.
Dated: October 9, 2019.
William T. McDermott,
Acting Assistant Administrator.
[FR Doc. 2019-23012 Filed 10-21-19; 8:45 am]
BILLING CODE 4410-09-P
